Trial intelligence / Profile preview

Clofarabine Induction and Haplo-SCT in Refractory Pediatric Leukemia

NCT01025778Phase 2Completed

Sponsor
Skåne University Hospital
Start
Dec 2009
Primary completion
Dec 2012
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of clofarabine in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), sponsored by Skåne University Hospital. Started Dec 2009; status: completed.

02

Drugs

clofarabine
03

Conditions

acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)

Beyond the preview

Go deeper on NCT01025778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01025778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call